• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌和合生菌对结直肠手术后伤口感染并发症的影响:一项荟萃分析。

Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta-analysis.

机构信息

Pharmaceutical Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.

Department of Laboratory Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.

出版信息

Int Wound J. 2024 Apr;21(4):e14838. doi: 10.1111/iwj.14838.

DOI:10.1111/iwj.14838
PMID:38577937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10996049/
Abstract

Wound infection is a serious complication that impacts the prognosis of patients after colorectal surgery (CS). Probiotics and synbiotics (Pro and Syn) are live bacteria that produce bacteriostatic agents in the intestinal system and have a positive effect on postoperative wound infections. The purpose of this study was to evaluate the effect of Pro and Syn on complications of wound infection after CS. In November 2023, we searched relevant clinical trial reports from Pubmed, Cochrane Library, and Embase databases and screened the retrieved reports, extracted data, and finally analysed the data by using RevMan 5.3. A total of 12 studies with 1567 patients were included in the study. Pro and Syn significantly reduced total infection (OR, 0.44; 95% CI, 0.35, 0.56; p < 0.00001), surgical incision site infection (SSI) (OR, 0.61; 95% CI, 0.45, 0.81; p = 0.002), pneumonia (OR, 0.43; 95% CI, 0.25, 0.72; p = 0.001), urinary tract infection (OR, 0.28; 95% CI, 0.14, 0.56; p = 0.0003), and Pro and Syn did not reduce anastomotic leakage after colorectal surgery (OR, 0.84; 95% CI, 0.50, 1.41; p = 0.51). Pro and Syn can reduce postoperative wound infections in patients with colorectal cancer, which benefits patients' postoperative recovery.

摘要

伤口感染是结直肠手术后(CS)患者预后的严重并发症。益生菌和合生剂(Pro 和 Syn)是在肠道系统中产生抑菌剂并对术后伤口感染有积极影响的活菌。本研究旨在评估 Pro 和 Syn 对 CS 后伤口感染并发症的影响。2023 年 11 月,我们检索了 Pubmed、Cochrane Library 和 Embase 数据库中的相关临床试验报告,并筛选了检索到的报告,提取数据,最后使用 RevMan 5.3 分析数据。共有 12 项研究纳入了 1567 名患者。Pro 和 Syn 显著降低了总感染(OR,0.44;95%CI,0.35,0.56;p<0.00001)、手术切口部位感染(SSI)(OR,0.61;95%CI,0.45,0.81;p=0.002)、肺炎(OR,0.43;95%CI,0.25,0.72;p=0.001)、尿路感染(OR,0.28;95%CI,0.14,0.56;p=0.0003),但 Pro 和 Syn 并未降低结直肠手术后的吻合口漏(OR,0.84;95%CI,0.50,1.41;p=0.51)。Pro 和 Syn 可减少结直肠癌患者术后伤口感染,有利于患者术后恢复。

相似文献

1
Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta-analysis.益生菌和合生菌对结直肠手术后伤口感染并发症的影响:一项荟萃分析。
Int Wound J. 2024 Apr;21(4):e14838. doi: 10.1111/iwj.14838.
2
Probiotics/Synbiotics to Reduce Infectious Complications after Colorectal Surgery: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.益生菌/合生菌减少结直肠手术后感染并发症:随机对照试验的系统评价和荟萃分析。
Nutrients. 2022 Jul 26;14(15):3066. doi: 10.3390/nu14153066.
3
Probiotics and synbiotics for preventing postoperative infectious complications in colorectal cancer patients: a systematic review and meta-analysis.益生菌和合生菌预防结直肠癌患者术后感染性并发症的效果:系统评价和荟萃分析。
Tech Coloproctol. 2022 Jun;26(6):425-436. doi: 10.1007/s10151-022-02585-1. Epub 2022 Mar 29.
4
The effect of pro/synbiotics on postoperative infections in colorectal cancer patients: A systematic review and meta-analysis.益生菌/合生剂对结直肠癌患者术后感染的影响:系统评价和荟萃分析。
Complement Ther Clin Pract. 2021 May;43:101370. doi: 10.1016/j.ctcp.2021.101370. Epub 2021 Apr 1.
5
Probiotics for preventing postoperative infection in colorectal cancer patients: a systematic review and meta-analysis.益生菌预防结直肠癌患者术后感染:一项系统评价和荟萃分析。
Int J Colorectal Dis. 2019 Mar;34(3):459-469. doi: 10.1007/s00384-018-3214-4. Epub 2018 Dec 11.
6
The effect of probiotics on postsurgical complications in patients with colorectal cancer: a systematic review and meta-analysis.益生菌对结直肠癌患者术后并发症的影响:一项系统评价和荟萃分析。
Nutr Rev. 2023 Apr 11;81(5):493-510. doi: 10.1093/nutrit/nuac069.
7
Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: A meta-analysis with trial sequential analysis of randomized controlled trials.围手术期补充益生菌/合生菌对手术患者临床结局的影响:一项随机对照试验的荟萃分析及试验序贯分析。
Clin Nutr. 2018 Apr;37(2):505-515. doi: 10.1016/j.clnu.2016.10.015. Epub 2016 Oct 26.
8
Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: a meta-analysis of randomized controlled trials.应用益生菌/合生剂作为预防措施在接受结直肠切除术的癌症患者中的效果:一项随机对照试验的荟萃分析。
Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):406-15. doi: 10.1016/j.clinre.2012.10.007. Epub 2012 Nov 20.
9
Comparative effectiveness of oral antibiotics, probiotics, prebiotics, and synbiotics in the prevention of postoperative infections in patients undergoing colorectal surgery: A network meta-analysis.口服抗生素、益生菌、益生元和合生元在预防结直肠手术后患者术后感染中的疗效比较:网络荟萃分析。
Int Wound J. 2023 Feb;20(2):567-578. doi: 10.1111/iwj.13888. Epub 2022 Jul 7.
10
The effect of perioperative probiotics and synbiotics on postoperative infections in patients undergoing major liver surgery: a meta-analysis of randomized controlled trials.围手术期益生菌和合生元对接受大肝手术患者术后感染的影响:一项随机对照试验的荟萃分析。
PeerJ. 2025 Feb 17;13:e18874. doi: 10.7717/peerj.18874. eCollection 2025.

引用本文的文献

1
RETRACTION: Effect of Probiotics and Synbiotics on Complications of Wound Infection after Colorectal Surgery: A Meta-Analysis.撤稿声明:益生菌和合生元对结直肠手术后伤口感染并发症的影响:一项荟萃分析。
Int Wound J. 2025 Apr;22(4):e70407. doi: 10.1111/iwj.70407.
2
Microbiota modifications in prehabilitation - the next step towards comprehensive preparation for surgery. The scoping review.术前康复中的微生物群改变——迈向手术全面准备的下一步。范围综述。
Prz Gastroenterol. 2024;16(4):347-361. doi: 10.5114/pg.2024.145833. Epub 2024 Dec 11.

本文引用的文献

1
Probiotics/Synbiotics to Reduce Infectious Complications after Colorectal Surgery: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.益生菌/合生菌减少结直肠手术后感染并发症:随机对照试验的系统评价和荟萃分析。
Nutrients. 2022 Jul 26;14(15):3066. doi: 10.3390/nu14153066.
2
Evidence-based Prevention of Surgical Site Infection.基于证据的手术部位感染预防。
Surg Clin North Am. 2021 Dec;101(6):951-966. doi: 10.1016/j.suc.2021.05.027.
3
Usage of Probiotics and its Clinical Significance at Surgically Treated Patients Sufferig from Colorectal Carcinoma.
益生菌在接受手术治疗的结直肠癌患者中的应用及其临床意义
Med Arch. 2019 Oct;73(5):316-320. doi: 10.5455/medarh.2019.73.316-320.
4
Probiotics for preventing postoperative infection in colorectal cancer patients: a systematic review and meta-analysis.益生菌预防结直肠癌患者术后感染:一项系统评价和荟萃分析。
Int J Colorectal Dis. 2019 Mar;34(3):459-469. doi: 10.1007/s00384-018-3214-4. Epub 2018 Dec 11.
5
Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.美国医院中与医疗保健相关的感染的患病率变化。
N Engl J Med. 2018 Nov 1;379(18):1732-1744. doi: 10.1056/NEJMoa1801550.
6
Impact of the preoperative use of synbiotics in colorectal cancer patients: A prospective, randomized, double-blind, placebo-controlled study.术前使用合生剂对结直肠癌患者的影响:一项前瞻性、随机、双盲、安慰剂对照研究。
Nutrition. 2019 Feb;58:40-46. doi: 10.1016/j.nut.2018.06.004. Epub 2018 Jul 11.
7
Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial.围手术期给予合生元可降低结直肠癌患者术后感染率:一项随机双盲临床试验
Rev Col Bras Cir. 2017 Nov-Dec;44(6):567-573. doi: 10.1590/0100-69912017006004.
8
The Presence of Postoperative Infectious Complications is Associated with the Risk of Early Postoperative Clinical Recurrence of Crohn's Disease.术后感染性并发症的存在与克罗恩病术后早期临床复发风险相关。
World J Surg. 2017 Sep;41(9):2371-2377. doi: 10.1007/s00268-017-4026-3.
9
Impact of probiotics on necrotizing enterocolitis.益生菌对坏死性小肠结肠炎的影响。
Semin Perinatol. 2017 Feb;41(1):41-51. doi: 10.1053/j.semperi.2016.09.017. Epub 2016 Nov 8.
10
The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial.围手术期益生菌治疗对结直肠癌的影响:一项随机对照试验的短期结果
Oncotarget. 2016 Feb 16;7(7):8432-40. doi: 10.18632/oncotarget.7045.